
Ministers urged to provide more graduate training slots for UK medical students
Dr Peter Prinsley, a retired ENT (ear, nose and throat) specialist who was elected for Labour last year, said thousands of British medicine graduates were missing out on doing further training every year because of a lack of places combined with the pressures from international medical graduates in the NHS.
The British Medical Association has said about 20,000 applicants will miss out this year, if the number of available posts are the same. It added that according to the latest figures, there were 4.7 applications per post.
The MP for Bury St Edmunds and Stowmarket said it had led to graduates moving abroad to do further study who sometimes do not return. He added there should be reserved spaces for UK graduates to be able to specialise and do further study.
Dr Prinsley told the PA news agency: 'The problem is that we've got a distorted competition ratio for the professional training slots.
'It should be a reasonable expectation that if you graduate from the UK medical school, you should have a reasonable chance of getting into higher professional training.
'There should be some competition. It shouldn't just be that you automatically progress with no effort, there should be a bit of competition, but the competition ratios have been hugely distorted by the requirement of the hospitals to provide junior doctors to staff their rotas.'
It comes as Wes Streeting said UK medical graduates will be given priority for NHS jobs under the upcoming 10-year health plan.
The Health Secretary told medical website doctors.net.uk on Thursday: 'I want to make sure that if you go through your medical training here in the UK, that you're able to work in the UK.'
Mr Streeting added it was 'completely bonkers' to invest in training doctors but not ensure they can stay in the UK to work.
The latest figures from the BMA showed there were 33,108 medical graduates applying for around 13,000 posts. This includes 12,305 UK graduates and 20,803 from overseas.
The number of international medical graduates has doubled in two years, the figures show, while the UK ones have only risen by a third.
The sharp rise in the number of international medical graduates has been down to the increased demand for doctors in the NHS to fill hospital vacancies.
In 2023 more than two-thirds of new doctors (68%) joining the NHS were non-UK graduates, up from 47% in 2017.
In a statement, the Department for Health and Social Care said the Government should not be 'over-reliant' on overseas recruitment.
Doctors can go on to do further training after two foundation years in the NHS.
If they apply and miss out on further study, they then move on to so-called foundation three status, where they can work as locums and apply for jobs within individual trusts. Some, however, opt to move abroad to work or study.
The number doing another foundation year has risen in recent years. In its latest workforce report, the General Medical Council said the number of doctors not going into speciality training had grown and was a 'sizeable' part of the workforce.
Dr Prinsley said he believes priority should be given to UK graduates and physician associates – who have less training – could be used to fill some of the roles taken up by overseas recruits.
He said: 'The change that we need is not very difficult. We just need to make a situation in which we prioritise the UK training slots for the UK medical graduates. If we've got any slots we can't recruit to, then, of course, we extend it.'
He added: 'The problem has two solutions. We need less international medical graduates being recruited by the hospitals. We need to find an alternative way of staffing the rotas to run the hospitals.
'There's a sort of golden mean, which would allow us to sort out the ratios of international medical graduates to British graduates, and also provide a meaningful role for these graduates as physician associates.'
The British Medical Association will discuss the issue at its annual conference in Liverpool on Monday. In a motion put forward by members in the East Midlands, it asks the Government to 'significantly increase the number of training posts available for resident doctors'.
It echoes a similar call by the Royal College of Physicians, who wrote in February 'UK graduates must be supported and enabled to enter postgraduate training schemes to continue their training in the NHS'.
A Department of Health and Social Care spokesperson said: 'We are committed to building home-grown talent and ensuring UK medical graduates can find work in Britain – our 10 year health plan will tackle bottlenecks in the system.
'Internationally-trained staff remain an important part of the workforce but we should not be over reliant on overseas recruitment.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
40 minutes ago
- Daily Mirror
NHS urges many people between 25 and 64 to put on key phone alert
Invitations to specific health examinations are now being issued through the NHS mobile app - here's what you need to know Certain Android and iPhone users aged 25 and 64 are encouraged to download the NHS app for important updates. This specifically regards women, trans people and anyone else with a cervix, which describes the neck of the uterus. This morning, the NHS issued a crucial alert about its mobile app on X, formerly Twitter. It stressed: "Cervical screening invitations are now being sent through the NHS App for women and people with a cervix between the ages of 25 and 64. "One - Download the NHS App. Two - Turn on notifications. Three - Book and attend your appointment, when invited." Cervical screenings, commonly called smear tests, are conducted to assess the health of the cervix and aid in preventing cancer. Generally, the examination takes around five minutes and involves undressing from the waist down before lying on a bed. A nurse will then insert a tube-shaped speculum into the vagina and expand it to visualise the cervix, from which cell samples will be collected using a small brush. Medical professionals are particularly interested in types of 'human papillomavirus (HPV)', a widespread group of viruses that may lead to changes in the cervix. HPV spreads through multiple means, including sexual activity, skin-to-skin contact in the genital area, and sharing sex toys. Although the body can eliminate HPV without difficulty, certain types may persist for an extended period. In severe instances, high-risk HPV types could lead to genital warts or cervical cancer. "Cervical screening checks the health of your cervix and helps find any abnormal changes before they can turn into cancer," further NHS guidance explains. "It's not a test for cancer, it's a test to help prevent cancer. Cervical screening checks a sample of cells from your cervix for certain types of human papillomavirus (HPV). "These types of HPV can cause abnormal changes to the cells in your cervix and are called 'high risk' types of HPV. If high-risk types of HPV are found during screening, the sample of cells is also checked for abnormal cell changes. If abnormal cells are found, they can be treated so they do not get a chance to turn into cervical cancer." While 25 to 49-year-olds are typically invited to take a screening every three years, 50 to 64-year-olds are invited every five years. Anyone aged 65 or above may be asked if a recent examination was abnormal. Invitations are sent through the NHS app, as well as via text or mail. Am I at risk of cervical cancer? People with a cervix might be at risk of cervical cancer if they have engaged in 'any kind of sexual contact'. This includes: Vaginal, oral or anal sex Any skin-to-skin contact with the genital area Sharing sex toys This also applies in the following cases: You have only ever had one sexual partner, or you've had the same partner for a long time You are lesbian or bisexual You are a trans man with a cervix You have received the HPV vaccine You have undergone a partial hysterectomy that did not remove all of your cervix


Daily Record
40 minutes ago
- Daily Record
Who is eligible for Mounjaro as weight loss jab becomes available from GPs?
Here's who will be able to get Mounjaro, that treats types 2 diabetes and aids weight loss, on the NHS Weight-loss injections have surged in popularity over the last couple of years, fuelled by celebrity endorsements and social media exposure. And one jab that's capturing public attention and dominating headlines is Mounjaro. Tirzepatide, to give the treatment its medical name, is a prescription injectable medication designed to help adults with type 2 diabetes better manage their blood sugar levels. When combined with a healthy diet and regular exercise, it can significantly improve glucose control, supporting a more balanced approach to diabetes management. While originally developed to manage type 2 diabetes, Mounjaro has been licensed in the UK to treat obesity since November 2024, and is effective in helping patients achieve significant weight loss. Mounjaro received approval from NICE (National Institute for Health and Care Excellence) for treating obesity in England, Wales and Northern Ireland. Scotland had already approved Tirzepatide for obesity treatment through the Scottish Medicines Consortium, leading the way in making this medication available to patients. But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as the health service begins its mass rollout. Some 220,000 people with the "greatest need" are expected to receive Mounjaro, made by pharmaceutical company Lilly, through the NHS over the next three years. So, amid the recent change, who is actually eligible for Mounjaro? According to NHS England, the first group of patients who will be able to get the jab from their GP or a community clinic, will be those most in need. In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of more than 40 who have at least four other health problems linked to obesity, such as: type 2 diabetes; high blood pressure; heart disease; and obstructive sleep apnoea. It was previously only accessible to patients through a special weight loss service, to severely obese people who also suffer from a range of other health problems. People will also get "wrap-around" care - including support with exercising and following a healthy diet, for example. But prescriptions for the drug will not necessarily be available from all local GPs, according to the BBC. In some cases, they will come from other primary care services. Some GP practices have issued notices on their websites saying very few patients on their lists, external will qualify for the medicine straight away and if anyone doesn't meet the criteria, they should not book an appointment. What's more, according to the Company Chemists' Association, the trade association for large pharmacies, it is not looking too promising that all patients who want Mounjaro and meet the criteria will get it straight away. Chief executive Malcolm Harrison said "it is unlikely that the planned GP provision will be sufficient to meet patient demand". The drug is usually delivered through a self-administered weekly injection which a doctor or nurse will show patients how to use, the NHS website says. Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News has established. Here, health boards make decisions on which medicines are available in their areas. In the same breath that we talk about people who are eligible for Mounjaro, there are groups who cannot take it. Mounjaro is not recommended for those who are pregnant or planning to get pregnant, breastfeeding or have certain health conditions, according to the NHS. For those taking the contraceptive pill and using Tirzepatide, the NHS recommends using an additional method of contraception, such as a condom, for the first four weeks of treatment and for four weeks after each dose increase as the contraceptive pill may not be absorbed by the body during this time. Join the Daily Record WhatsApp community!


BBC News
an hour ago
- BBC News
National investigation into maternity care announced
Health Secretary Wes Streeting has announced a national investigation into maternity care in "rapid" inquiry will urgently look at the worst-performing maternity and neonatal services in the country, including Leeds, Sussex, Gloucester, and Mid and South has met parents who have lost babies in a series of maternity scandals at some NHS trusts and said the investigation would "make sure these families get the truth and the accountability they deserve". It will begin this summer and report back by December 2025. The review will look across the entire maternity system, bringing together the findings of past reviews into a clear national set of actions to ensure every woman and baby receives safe, high-quality and compassionate the announcement on Monday, Streeting apologised on behalf of the NHS to those families who had suffered avoidable comes after a series of maternity scandals, including in Morecambe Bay, East Kent, Shrewsbury and Telford and said the review would be co-produced with the victims of maternity scandals, giving families a voice into how the inquiry is said he wants to ensure "no parent or baby is ever let down again".